Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
NeuroVive and Yungjin Pharm Start Clinical Development in Genetic Mitochondrial Disease
Wednesday, June 28, 2017NeuroVive Pharmaceutical AB and Yungjin Pharm Corporation Ltd announced that the clinical phase I study of KL has started in Korea and that the first healthy volunteer has been enrolled The study is a doubleblind placebocontrolled singledose dosee...
Semnur Pharmaceuticals, Inc., Announces Successful Phase 1 / 2 Trial in Patients with Radicular Pain for Its Lead Product, SP-102
Tuesday, June 27, 2017Semnur Pharmaceuticals Inc announced successful Phase pharmacokinetic bridging trial of the lead product SP The trial was conducted in the patients with radicular pain achieved its primary pharmacokinetic endpoint and also demonstrated that a sing...
Breckenridge Pharmaceutical, Inc. Announces Final ANDA Approval for Azacitidine for Injection (Vidaza®)
Tuesday, June 27, 2017Breckenridge Pharmaceutical Inc announced that FDA has granted final approval of its ANDA Azacitidine for Injection mg per vial SingleDose Vial a generic version of Vidaza by Celgene Corporation Breckenridge submitted the ANDA with its development an...
Enanta Announces that AbbVie Receives CHMP Positive Opinion for MAVIRET™ (glecaprevir/pibrentasvir)
Saturday, June 24, 2017Enanta Pharmaceuticals Inc a research and developmentfocused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases today announced that the European Committee for Medicinal Products for Human Use CHM...
Novo Nordisk says obesity drug helps up to 13.8 percent weight loss in phase 2 trial
Saturday, June 24, 2017Danish drugmaker Novo Nordisk said on Friday a phase trial for its big hope in tackling obesity an improved GLP drug called semaglutide showed a weight loss of up to percent in people with severe conditions The clinical trial which lasted a year...
DURECT Completes Enrollment in PERSIST, Phase 3 trial for POSIMIR®
Friday, June 23, 2017DURECT Corporation announced that patient enrollment has been completed in PERSIST the pivotal Phase clinical trial of POSIMIR SABERBupivacaine an investigational locally acting nonopioid analgesic intended to provide up to three days of continuous...
Eisai and Ewopharma Announce Commercial Partnership
Friday, June 23, 2017Ewopharma a pharmaceutical marketing company and Eisai Co Ltd TYO a leading global research and developmentbased pharmaceutical company are pleased to announce that as of st April Ewopharma acquired the rights to commercialise several of Eisais pro...
Seqirus Announces Next Major Advancement in Cell-Based Influenza Vaccine Technology
Thursday, June 22, 2017Seqirus a leading innovator in influenza vaccines and pandemic preparedness today announced the next major advancement in the use of cellbased technology at its stateofthe art manufacturing facility in Holly Springs North Carolina In an industry f...
GSK wins $235 million from Teva in Coreg patent trial
Thursday, June 22, 2017A US jury has ordered Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc more than million for infringing a patent covering its blood pressure drug Coreg court documents showed A federal jury in Wilmington Delaware on Tuesday found tha...
Icagen and Omdana Therapeutics Announce Collaboration to Pursue Therapies for Patients with Pulmonary Hypertension
Wednesday, June 21, 2017Icagen Inc and Omdana Therapeutics Inc announced a collaboration to help advance the discovery of novel medicines for disorders related to tissue homeostasis and vascular remodeling such as pulmonary hypertension Omdana a company cofounded by pharma...
